1 not yet recruiting, 1 recruiting, 1 suspended, 1 terminated. 4 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 1, Recruiting 1, Suspended 1, Withdrawn 1 |
| Not applicable | 1 | Terminated 1 |
Follow Resectable Intrahepatic Cholangiocarcinoma: new trials by email Literature Review of Resectable Intrahepatic Cholangiocarcinoma trials Research Report on Resectable Intrahepatic Cholangiocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma | Phase 2 | Not yet recruiting | Northwestern University | 44 | 2027-12-10 | 2026-06-10 |
| Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery Biopsy Procedure, Biospecimen Collection, Cisplatin - Resectable Intrahepatic Cholangiocarcinoma | Phase 2 | Suspended | National Cancer Institute (NCI) | 27 | 2024-07-10 | 2026-09-04 |
| Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial Cisplatin, Gemcitabine Hydrochloride, Infigratinib Phosphate - Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 | Phase 2 | Withdrawn | Emory University | 2024-03-01 | 2023-12-26 | |
| Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer Capecitabine, Selective Internal Radiotherapy (SIRT), Surgery - Resectable Intrahepatic Cholangiocarcinoma | Phase 2 | Recruiting | Center Eugene Marquis | 62 | 2022-02-04 | 2025-08-06 |
| A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma Gemcitabine, Cisplatin, Surgery - Unresectable Intrahepatic Cholangiocarcinoma, Resectable Intrahepatic Cholangiocarcinoma | Not applicable | Terminated | Massachusetts General Hospital | 3 | 2014-10-01 | 2016-04-13 |
Adenocarcinoma (1) · Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Cisplatin (4) · Gemcitabine (4) · 1,2-diaminocyclohexaneplatinum II citrate (3) · Platinum (3) · Disulfides (2) · Immunoglobulin G (2) · Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · Surgical Procedures, Operative (2) · durvalumab (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Biopsy (1) · Capecitabine (1) · Radiation (1)
Center Eugene Marquis (1) · Emory University (1) · Massachusetts General Hospital (1) · National Cancer Institute (NCI) (1) · Northwestern University (1)
United States (3) · France (1)
Hop S Tran Cao (1) · Julien Edeline, MD (1) · Shishir K Maithel, MD (1) · Shishir K. Maithel, MD (1) · Theodore S. Hong, MD (1)
P30CA060553 (1), P30CA138292 (1), UM1CA186688 (1)